Polypharmacy.
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will use the Pill Path Planner, a device designed and developed by the research team. It includes 7 pages corresponding to the days of the we
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals aged 60 years or older Having at least one chronic disease Ability to communicate verbally Taking 5 to 12 medications daily Self-administration of medications based on self-report Owning a smartphone Having at least basic Persian reading literacy
Exclusion criteria
Exclusion criteria: Having a cognitive impairment identified based on self-report Having severe visual impairment or being blind
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The self-efficacy in medication use score is measured using the standardized Self-Efficacy for Appropriate Medication Use Scale (SEAMS) questionnaire. Timepoint: The self-efficacy in medication use will be measured at the study’s outset (before intervention) and after 8 weeks. Method of measurement: Self-efficacy for Appropriate Medication Use Scale (SEAMS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication adherence score. Timepoint: Medication adherence will be measured at the study’s outset (before intervention) and after 8 weeks. Method of measurement: Hill-Bone Medication Adherence Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohaddeseh Bahmani
Tehran University of Medical Sciences
Outcome results
None listed